APO Research
Talk to an analyst

APO RESEARCH · REPORT

Alvimopan

Alvimopan, CAS 156053-89-3, (trade name Entereg) is a drug, which behaves as a peripherally acting μ-opioid receptor antagonist. It is currently only Food and Drug Administration approved for the treatment of postoperative ileus, which it received in May 2008.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Alvimopan, CAS 156053-89-3, (trade name Entereg) is a drug, which behaves as a peripherally acting μ-opioid receptor antagonist. It is currently only Food and Drug Administration approved for the treatment of postoperative ileus, which it received in May 2008.

Selected research

Market Analysis & Forecast

Global Alvimopan Market Analysis and Forecast 2026-2032

28 December 2025192 pages

Choose your research edition.

Industry ResearchAlvimopan Industry Research Report 2026114 pages · $2,950 USDIndustry Growth & TrendsGlobal Alvimopan Industry Growth and Trends Forecast to 203273 pages · $3,450 USDMarket StructureGlobal Alvimopan Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032173 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Alvimopan Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Alvimopan Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

Alvimopan, CAS 156053-89-3, (trade name Entereg) is a drug, which behaves as a peripherally acting μ-opioid receptor antagonist. It is currently only Food and Drug Administration approved for the treatment of postoperative ileus, which it received in May 2008.

Alvimopan (CAS 156053-89-3) is widely used in Pharmaceutical and Other field. The most proportion of Alvimopan (CAS 156053-89-3) is used in Pharmaceutical, and the proportion in 2019 is 88.64%. Market competition is intense. Merck is the leaders of the industry, and they hold key technologies and patents, with high-end customers.

This report presents an overview of global market for Alvimopan, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

Read the full market overview

This report researches the key producers of Alvimopan, also provides the sales of main regions and countries. Of the upcoming market potential for Alvimopan, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Alvimopan sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Alvimopan market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Alvimopan sales, projected growth trends, production technology, application and end-user industry.

Alvimopan Segment by Company

Merck

Teva Pharmaceutical Industries Ltd

MSN Life Sciences Private Ltd

Alvimopan Segment by Type

Pharmaceutical Grade

Others

Alvimopan Segment by Application

Pharmaceutical

Other

Alvimopan Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Alvimopan market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Alvimopan and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Alvimopan.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Alvimopan in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Alvimopan manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Alvimopan sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Alvimopan Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Pharmaceutical Grade Major Manufacturers Table 3. Others Major Manufacturers Table 4. Global Alvimopan Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Pharmaceutical Major Manufacturers Table 6. Other Major Manufacturers Table 7. Alvimopan Industry Trends Table 8. Alvimopan Industry Drivers Table 9. Alvimopan Industry Opportunities and Challenges Table 10. Alvimopan Industry Restraints Table 11. Global Alvimopan Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Alvimopan Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Alvimopan Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Alvimopan Revenue Market Share by Region (2021-2026) Table 15. Global Alvimopan Revenue Market Share by Region (2027-2032) Table 16. Global Alvimopan Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (KG) Table 17. Global Alvimopan Sales by Region (2021-2026) & (KG) Table 18. Global Alvimopan Sales by Region (2027-2032) & (KG) Table 19. Global Alvimopan Sales Market Share by Region (2021-2026) Table 20. Global Alvimopan Sales Market Share by Region (2027-2032) Table 21. Global Alvimopan Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Alvimopan Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Alvimopan Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Alvimopan Sales Market Share by Manufacturers (2021-2026) Table 25. Global Alvimopan Sales Price (US$/g) of Manufacturers (2021-2026) Table 26. Global Alvimopan Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Alvimopan Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Alvimopan Manufacturers, Product Type & Application Table 29. Global Alvimopan Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Alvimopan by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Alvimopan Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Alvimopan Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Alvimopan Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Alvimopan Revenue Market Share by Type (2021-2026) Table 36. Global Alvimopan Revenue Market Share by Type (2027-2032) Table 37. Global Alvimopan Sales by Type 2021 VS 2025 VS 2032 (KG) Table 38. Global Alvimopan Sales by Type (2021-2026) & (KG) Table 39. Global Alvimopan Sales by Type (2027-2032) & (KG) Table 40. Global Alvimopan Sales Market Share by Type (2021-2026) Table 41. Global Alvimopan Sales Market Share by Type (2027-2032) Table 42. Global Alvimopan Price by Type (2021-2026) & (US$/g) Table 43. Global Alvimopan Price by Type (2027-2032) & (US$/g) Table 44. Global Alvimopan Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Alvimopan Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Alvimopan Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Alvimopan Revenue Market Share by Application (2021-2026) Table 48. Global Alvimopan Revenue Market Share by Application (2027-2032) Table 49. Global Alvimopan Sales by Application 2021 VS 2025 VS 2032 (KG) Table 50. Global Alvimopan Sales by Application (2021-2026) & (KG) Table 51. Global Alvimopan Sales by Application (2027-2032) & (KG) Table 52. Global Alvimopan Sales Market Share by Application (2021-2026) Table 53. Global Alvimopan Sales Market Share by Application (2027-2032) Table 54. Global Alvimopan Price by Application (2021-2026) & (US$/g) Table 55. Global Alvimopan Price by Application (2027-2032) & (US$/g) Table 56. Merck Company Information Table 57. Merck Business Overview Table 58. Merck Alvimopan Sales (KG), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 59. Merck Alvimopan Product Portfolio Table 60. Merck Recent Development Table 61. Teva Pharmaceutical Industries Ltd Company Information Table 62. Teva Pharmaceutical Industries Ltd Business Overview Table 63. Teva Pharmaceutical Industries Ltd Alvimopan Sales (KG), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 64. Teva Pharmaceutical Industries Ltd Alvimopan Product Portfolio Table 65. Teva Pharmaceutical Industries Ltd Recent Development Table 66. MSN Life Sciences Private Ltd Company Information Table 67. MSN Life Sciences Private Ltd Business Overview Table 68. MSN Life Sciences Private Ltd Alvimopan Sales (KG), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 69. MSN Life Sciences Private Ltd Alvimopan Product Portfolio Table 70. MSN Life Sciences Private Ltd Recent Development Table 71. North America Alvimopan Revenue by Type (2021-2026) & (US$ Million) Table 72. North America Alvimopan Revenue by Type (2027-2032) & (US$ Million) Table 73. North America Alvimopan Sales by Type (2021-2026) & (KG) Table 74. North America Alvimopan Sales by Type (2027-2032) & (KG) Table 75. North America Alvimopan Sales Price by Type (2021-2026) & (US$/g) Table 76. North America Alvimopan Sales Price by Type (2027-2032) & (US$/g) Table 77. North America Alvimopan Revenue by Application (2021-2026) & (US$ Million) Table 78. North America Alvimopan Revenue by Application (2027-2032) & (US$ Million) Table 79. North America Alvimopan Sales by Application (2021-2026) & (KG) Table 80. North America Alvimopan Sales by Application (2027-2032) & (KG) Table 81. North America Alvimopan Sales Price by Application (2021-2026) & (US$/g) Table 82. North America Alvimopan Sales Price by Application (2027-2032) & (US$/g) Table 83. North America Alvimopan Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 84. North America Alvimopan Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 85. North America Alvimopan Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 86. North America Alvimopan Sales by Country (2021 VS 2025 VS 2032) & (KG) Table 87. North America Alvimopan Sales by Country (2021-2026) & (KG) Table 88. North America Alvimopan Sales by Country (2027-2032) & (KG) Table 89. North America Alvimopan Sales Price by Country (2021-2026) & (US$/g) Table 90. North America Alvimopan Sales Price by Country (2027-2032) & (US$/g) Table 91. United States Alvimopan Revenue (2021-2032) & (US$ Million) Table 92. Canada Alvimopan Revenue (2021-2032) & (US$ Million) Table 93. Mexico Alvimopan Revenue (2021-2032) & (US$ Million) Table 94. Europe Alvimopan Revenue by Type (2021-2026) & (US$ Million) Table 95. Europe Alvimopan Revenue by Type (2027-2032) & (US$ Million) Table 96. Europe Alvimopan Sales by Type (2021-2026) & (KG) Table 97. Europe Alvimopan Sales by Type (2027-2032) & (KG) Table 98. Europe Alvimopan Sales Price by Type (2021-2026) & (US$/g) Table 99. Europe Alvimopan Sales Price by Type (2027-2032) & (US$/g) Table 100. Europe Alvimopan Revenue by Application (2021-2026) & (US$ Million) Table 101. Europe Alvimopan Revenue by Application (2027-2032) & (US$ Million) Table 102. Europe Alvimopan Sales by Application (2021-2026) & (KG) Table 103. Europe Alvimopan Sales by Application (2027-2032) & (KG) Table 104. Europe Alvimopan Sales Price by Application (2021-2026) & (US$/g) Table 105. Europe Alvimopan Sales Price by Application (2027-2032) & (US$/g) Table 106. Europe Alvimopan Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 107. Europe Alvimopan Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 108. Europe Alvimopan Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 109. Europe Alvimopan Sales by Country (2021 VS 2025 VS 2032) & (KG) Table 110. Europe Alvimopan Sales by Country (2021-2026) & (KG) Table 111. Europe Alvimopan Sales by Country (2027-2032) & (KG) Table 112. Europe Alvimopan Sales Price by Country (2021-2026) & (US$/g) Table 113. Europe Alvimopan Sales Price by Country (2027-2032) & (US$/g) Table 114. Germany Alvimopan Revenue (2021-2032) & (US$ Million) Table 115. France Alvimopan Revenue (2021-2032) & (US$ Million) Table 116. U.K. Alvimopan Revenue (2021-2032) & (US$ Million) Table 117. Italy Alvimopan Revenue (2021-2032) & (US$ Million) Table 118. Russia Alvimopan Revenue (2021-2032) & (US$ Million) Table 119. Spain Alvimopan Revenue (2021-2032) & (US$ Million) Table 120. Netherlands Alvimopan Revenue (2021-2032) & (US$ Million) Table 121. Switzerland Alvimopan Revenue (2021-2032) & (US$ Million) Table 122. Sweden Alvimopan Revenue (2021-2032) & (US$ Million) Table 123. Poland Alvimopan Revenue (2021-2032) & (US$ Million) Table 124. China Alvimopan Revenue by Type (2021-2026) & (US$ Million) Table 125. China Alvimopan Revenue by Type (2027-2032) & (US$ Million) Table 126. China Alvimopan Sales by Type (2021-2026) & (KG) Table 127. China Alvimopan Sales by Type (2027-2032) & (KG) Table 128. China Alvimopan Sales Price by Type (2021-2026) & (US$/g) Table 129. China Alvimopan Sales Price by Type (2027-2032) & (US$/g) Table 130. China Alvimopan Revenue by Application (2021-2026) & (US$ Million) Table 131. China Alvimopan Revenue by Application (2027-2032) & (US$ Million) Table 132. China Alvimopan Sales by Application (2021-2026) & (KG) Table 133. China Alvimopan Sales by Application (2027-2032) & (KG) Table 134. China Alvimopan Sales Price by Application (2021-2026) & (US$/g) Table 135. China Alvimopan Sales Price by Application (2027-2032) & (US$/g) Table 136. Asia Alvimopan Revenue by Type (2021-2026) & (US$ Million) Table 137. Asia Alvimopan Revenue by Type (2027-2032) & (US$ Million) Table 138. Asia Alvimopan Sales by Type (2021-2026) & (KG) Table 139. Asia Alvimopan Sales by Type (2027-2032) & (KG) Table 140. Asia Alvimopan Sales Price by Type (2021-2026) & (US$/g) Table 141. Asia Alvimopan Sales Price by Type (2027-2032) & (US$/g) Table 142. Asia Alvimopan Revenue by Application (2021-2026) & (US$ Million) Table 143. Asia Alvimopan Revenue by Application (2027-2032) & (US$ Million) Table 144. Asia Alvimopan Sales by Application (2021-2026) & (KG) Table 145. Asia Alvimopan Sales by Application (2027-2032) & (KG) Table 146. Asia Alvimopan Sales Price by Application (2021-2026) & (US$/g) Table 147. Asia Alvimopan Sales Price by Application (2027-2032) & (US$/g) Table 148. Asia Alvimopan Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 149. Asia Alvimopan Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 150. Asia Alvimopan Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 151. Asia Alvimopan Sales by Country (2021 VS 2025 VS 2032) & (KG) Table 152. Asia Alvimopan Sales by Country (2021-2026) & (KG) Table 153. Asia Alvimopan Sales by Country (2027-2032) & (KG) Table 154. Asia Alvimopan Sales Price by Country (2021-2026) & (US$/g) Table 155. Asia Alvimopan Sales Price by Country (2027-2032) & (US$/g) Table 156. Japan Alvimopan Revenue (2021-2032) & (US$ Million) Table 157. South Korea Alvimopan Revenue (2021-2032) & (US$ Million) Table 158. India Alvimopan Revenue (2021-2032) & (US$ Million) Table 159. Australia Alvimopan Revenue (2021-2032) & (US$ Million) Table 160. Taiwan Alvimopan Revenue (2021-2032) & (US$ Million) Table 161. Southeast Asia Alvimopan Revenue (2021-2032) & (US$ Million) Table 162. SAMEA Alvimopan Revenue by Type (2021-2026) & (US$ Million) Table 163. SAMEA Alvimopan Revenue by Type (2027-2032) & (US$ Million) Table 164. SAMEA Alvimopan Sales by Type (2021-2026) & (KG) Table 165. SAMEA Alvimopan Sales by Type (2027-2032) & (KG) Table 166. SAMEA Alvimopan Sales Price by Type (2021-2026) & (US$/g) Table 167. SAMEA Alvimopan Sales Price by Type (2027-2032) & (US$/g) Table 168. SAMEA Alvimopan Revenue by Application (2021-2026) & (US$ Million) Table 169. SAMEA Alvimopan Revenue by Application (2027-2032) & (US$ Million) Table 170. SAMEA Alvimopan Sales by Application (2021-2026) & (KG) Table 171. SAMEA Alvimopan Sales by Application (2027-2032) & (KG) Table 172. SAMEA Alvimopan Sales Price by Application (2021-2026) & (US$/g) Table 173. SAMEA Alvimopan Sales Price by Application (2027-2032) & (US$/g) Table 174. SAMEA Alvimopan Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 175. SAMEA Alvimopan Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 176. SAMEA Alvimopan Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 177. SAMEA Alvimopan Sales by Country (2021 VS 2025 VS 2032) & (KG) Table 178. SAMEA Alvimopan Sales by Country (2021-2026) & (KG) Table 179. SAMEA Alvimopan Sales by Country (2027-2032) & (KG) Table 180. SAMEA Alvimopan Sales Price by Country (2021-2026) & (US$/g) Table 181. SAMEA Alvimopan Sales Price by Country (2027-2032) & (US$/g) Table 182. Brazil Alvimopan Revenue (2021-2032) & (US$ Million) Table 183. Argentina Alvimopan Revenue (2021-2032) & (US$ Million) Table 184. Chile Alvimopan Revenue (2021-2032) & (US$ Million) Table 185. Colombia Alvimopan Revenue (2021-2032) & (US$ Million) Table 186. Peru Alvimopan Revenue (2021-2032) & (US$ Million) Table 187. Saudi Arabia Alvimopan Revenue (2021-2032) & (US$ Million) Table 188. Israel Alvimopan Revenue (2021-2032) & (US$ Million) Table 189. UAE Alvimopan Revenue (2021-2032) & (US$ Million) Table 190. Turkey Alvimopan Revenue (2021-2032) & (US$ Million) Table 191. Iran Alvimopan Revenue (2021-2032) & (US$ Million) Table 192. Egypt Alvimopan Revenue (2021-2032) & (US$ Million) Table 193. Key Raw Materials Table 194. Raw Materials Key Suppliers Table 195. Alvimopan Distributors List Table 196. Alvimopan Customers List Table 197. Research Programs/Design for This Report Table 198. Authors List of This Report Table 199. Secondary Sources Table 200. Primary Sources List of Figures Figure 1. Alvimopan Image Figure 2. Global Alvimopan Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Alvimopan Market Size Share 2021 VS 2025 VS 2032 Figure 4. Pharmaceutical Grade Image Figure 5. Others Image Figure 6. Global Alvimopan Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Alvimopan Market Size Share 2021 VS 2025 VS 2032 Figure 8. Pharmaceutical Image Figure 9. Other Image Figure 10. Global Alvimopan Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Alvimopan Revenue (2021-2032) & (US$ Million) Figure 12. Global Alvimopan Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Alvimopan Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Alvimopan Revenue Market Share by Region (2021-2032) Figure 15. Global Alvimopan Sales (2021-2032) & (KG) Figure 16. Global Alvimopan Sales by Region: 2021 VS 2025 VS 2032 (KG) Figure 17. Global Alvimopan Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Alvimopan Sales YoY (2021-2032) & (KG) Figure 19. Europe Alvimopan Sales YoY (2021-2032) & (KG) Figure 20. China Alvimopan Sales YoY (2021-2032) & (KG) Figure 21. Asia (Excluding China) Alvimopan Sales YoY (2021-2032) & (KG) Figure 22. South America, Middle East and Africa Alvimopan Sales YoY (2021-2032) & (KG) Figure 23. Global Alvimopan Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Alvimopan Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Alvimopan Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Alvimopan Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Alvimopan Revenue Market Share by Type (2021-2032) Figure 29. Global Alvimopan Sales by Type (2021 VS 2025 VS 2032) & (KG) Figure 30. Global Alvimopan Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Alvimopan Sales Market Share by Type (2021-2032) Figure 32. Global Alvimopan Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Alvimopan Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Alvimopan Revenue Market Share by Application (2021-2032) Figure 35. Global Alvimopan Sales by Application (2021 VS 2025 VS 2032) & (KG) Figure 36. Global Alvimopan Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Alvimopan Sales Market Share by Application (2021-2032) Figure 38. North America Alvimopan Revenue Share by Type (2021-2032) Figure 39. North America Alvimopan Sales Share by Type (2021-2032) Figure 40. North America Alvimopan Revenue Share by Application (2021-2032) Figure 41. North America Alvimopan Sales Share by Application (2021-2032) Figure 42. North America Alvimopan Revenue Share by Country (2021-2032) Figure 43. North America Alvimopan Sales Share by Country (2021-2032) Figure 44. Europe Alvimopan Revenue Share by Type (2021-2032) Figure 45. Europe Alvimopan Sales Share by Type (2021-2032) Figure 46. Europe Alvimopan Revenue Share by Application (2021-2032) Figure 47. Europe Alvimopan Sales Share by Application (2021-2032) Figure 48. Europe Alvimopan Revenue Share by Country (2021-2032) Figure 49. Europe Alvimopan Sales Share by Country (2021-2032) Figure 50. China Alvimopan Revenue Share by Type (2021-2032) Figure 51. China Alvimopan Sales Share by Type (2021-2032) Figure 52. China Alvimopan Revenue Share by Application (2021-2032) Figure 53. China Alvimopan Sales Share by Application (2021-2032) Figure 54. Asia Alvimopan Revenue Share by Type (2021-2032) Figure 55. Asia Alvimopan Sales Share by Type (2021-2032) Figure 56. Asia Alvimopan Revenue Share by Application (2021-2032) Figure 57. Asia Alvimopan Sales Share by Application (2021-2032) Figure 58. Asia Alvimopan Revenue Share by Country (2021-2032) Figure 59. Asia Alvimopan Sales Share by Country (2021-2032) Figure 60. SAMEA Alvimopan Revenue Share by Type (2021-2032) Figure 61. SAMEA Alvimopan Sales Share by Type (2021-2032) Figure 62. SAMEA Alvimopan Revenue Share by Application (2021-2032) Figure 63. SAMEA Alvimopan Sales Share by Application (2021-2032) Figure 64. SAMEA Alvimopan Revenue Share by Country (2021-2032) Figure 65. SAMEA Alvimopan Sales Share by Country (2021-2032) Figure 66. Alvimopan Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Alvimopan Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Pharmaceutical Grade
  • Others
Applications
  • Pharmaceutical
  • Other
Companies covered
  • Merck
  • Teva Pharmaceutical Industries Ltd
  • MSN Life Sciences Private Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Alvimopan Market by Type
  3. 1.2.1 Global Alvimopan Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Pharmaceutical Grade
  5. 1.2.3 Others
  6. 1.3 Alvimopan Market by Application
  7. 1.3.1 Global Alvimopan Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Pharmaceutical
  9. 1.3.3 Other
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Alvimopan Market Dynamics
  1. 2.1 Alvimopan Industry Trends
  2. 2.2 Alvimopan Industry Drivers
  3. 2.3 Alvimopan Industry Opportunities and Challenges
  4. 2.4 Alvimopan Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Alvimopan Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Alvimopan Revenue by Region
  3. 3.2.1 Global Alvimopan Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Alvimopan Revenue by Region (2021-2026)
  5. 3.2.3 Global Alvimopan Revenue by Region (2027-2032)
  6. 3.2.4 Global Alvimopan Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Alvimopan Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Alvimopan Sales by Region
  9. 3.4.1 Global Alvimopan Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Alvimopan Sales by Region (2021-2026)
  11. 3.4.3 Global Alvimopan Sales by Region (2027-2032)
  12. 3.4.4 Global Alvimopan Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Alvimopan Revenue by Manufacturers
  2. 4.1.1 Global Alvimopan Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Alvimopan Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Alvimopan Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Alvimopan Sales by Manufacturers
  6. 4.2.1 Global Alvimopan Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Alvimopan Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Alvimopan Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Alvimopan Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Alvimopan Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Alvimopan Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Alvimopan Manufacturers, Product Type & Application
  13. 4.7 Global Alvimopan Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Alvimopan Market CR5 and HHI
  16. 4.8.2 2025 Alvimopan Tier 1, Tier 2, and Tier 3
5 Alvimopan Market by Type
  1. 5.1 Global Alvimopan Revenue by Type
  2. 5.1.1 Global Alvimopan Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Alvimopan Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Alvimopan Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Alvimopan Sales by Type
  6. 5.2.1 Global Alvimopan Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Alvimopan Sales by Type (2021-2032) & (KG)
  8. 5.2.3 Global Alvimopan Sales Market Share by Type (2021-2032)
  9. 5.3 Global Alvimopan Price by Type
6 Alvimopan Market by Application
  1. 6.1 Global Alvimopan Revenue by Application
  2. 6.1.1 Global Alvimopan Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Alvimopan Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Alvimopan Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Alvimopan Sales by Application
  6. 6.2.1 Global Alvimopan Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Alvimopan Sales by Application (2021-2032) & (KG)
  8. 6.2.3 Global Alvimopan Sales Market Share by Application (2021-2032)
  9. 6.3 Global Alvimopan Price by Application
7 Company Profiles
  1. 7.1 Merck
  2. 7.1.1 Merck Company Information
  3. 7.1.2 Merck Business Overview
  4. 7.1.3 Merck Alvimopan Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Merck Alvimopan Product Portfolio
  6. 7.1.5 Merck Recent Developments
  7. 7.2 Teva Pharmaceutical Industries Ltd
  8. 7.2.1 Teva Pharmaceutical Industries Ltd Company Information
  9. 7.2.2 Teva Pharmaceutical Industries Ltd Business Overview
  10. 7.2.3 Teva Pharmaceutical Industries Ltd Alvimopan Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Teva Pharmaceutical Industries Ltd Alvimopan Product Portfolio
  12. 7.2.5 Teva Pharmaceutical Industries Ltd Recent Developments
  13. 7.3 MSN Life Sciences Private Ltd
  14. 7.3.1 MSN Life Sciences Private Ltd Company Information
  15. 7.3.2 MSN Life Sciences Private Ltd Business Overview
  16. 7.3.3 MSN Life Sciences Private Ltd Alvimopan Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 MSN Life Sciences Private Ltd Alvimopan Product Portfolio
  18. 7.3.5 MSN Life Sciences Private Ltd Recent Developments
8 North America
  1. 8.1 North America Alvimopan Market Size by Type
  2. 8.1.1 North America Alvimopan Revenue by Type (2021-2032)
  3. 8.1.2 North America Alvimopan Sales by Type (2021-2032)
  4. 8.1.3 North America Alvimopan Price by Type (2021-2032)
  5. 8.2 North America Alvimopan Market Size by Application
  6. 8.2.1 North America Alvimopan Revenue by Application (2021-2032)
  7. 8.2.2 North America Alvimopan Sales by Application (2021-2032)
  8. 8.2.3 North America Alvimopan Price by Application (2021-2032)
  9. 8.3 North America Alvimopan Market Size by Country
  10. 8.3.1 North America Alvimopan Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Alvimopan Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Alvimopan Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Alvimopan Market Size by Type
  2. 9.1.1 Europe Alvimopan Revenue by Type (2021-2032)
  3. 9.1.2 Europe Alvimopan Sales by Type (2021-2032)
  4. 9.1.3 Europe Alvimopan Price by Type (2021-2032)
  5. 9.2 Europe Alvimopan Market Size by Application
  6. 9.2.1 Europe Alvimopan Revenue by Application (2021-2032)
  7. 9.2.2 Europe Alvimopan Sales by Application (2021-2032)
  8. 9.2.3 Europe Alvimopan Price by Application (2021-2032)
  9. 9.3 Europe Alvimopan Market Size by Country
  10. 9.3.1 Europe Alvimopan Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Alvimopan Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Alvimopan Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Alvimopan Market Size by Type
  2. 10.1.1 China Alvimopan Revenue by Type (2021-2032)
  3. 10.1.2 China Alvimopan Sales by Type (2021-2032)
  4. 10.1.3 China Alvimopan Price by Type (2021-2032)
  5. 10.2 China Alvimopan Market Size by Application
  6. 10.2.1 China Alvimopan Revenue by Application (2021-2032)
  7. 10.2.2 China Alvimopan Sales by Application (2021-2032)
  8. 10.2.3 China Alvimopan Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Alvimopan Market Size by Type
  2. 11.1.1 Asia Alvimopan Revenue by Type (2021-2032)
  3. 11.1.2 Asia Alvimopan Sales by Type (2021-2032)
  4. 11.1.3 Asia Alvimopan Price by Type (2021-2032)
  5. 11.2 Asia Alvimopan Market Size by Application
  6. 11.2.1 Asia Alvimopan Revenue by Application (2021-2032)
  7. 11.2.2 Asia Alvimopan Sales by Application (2021-2032)
  8. 11.2.3 Asia Alvimopan Price by Application (2021-2032)
  9. 11.3 Asia Alvimopan Market Size by Country
  10. 11.3.1 Asia Alvimopan Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Alvimopan Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Alvimopan Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Alvimopan Market Size by Type
  2. 12.1.1 SAMEA Alvimopan Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Alvimopan Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Alvimopan Price by Type (2021-2032)
  5. 12.2 SAMEA Alvimopan Market Size by Application
  6. 12.2.1 SAMEA Alvimopan Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Alvimopan Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Alvimopan Price by Application (2021-2032)
  9. 12.3 SAMEA Alvimopan Market Size by Country
  10. 12.3.1 SAMEA Alvimopan Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Alvimopan Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Alvimopan Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Alvimopan Value Chain Analysis
  2. 13.1.1 Alvimopan Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Alvimopan Production Mode & Process
  6. 13.2 Alvimopan Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Alvimopan Distributors
  9. 13.2.3 Alvimopan Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst